Institutional shares held 331,530
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 0.98%
# of Institutions 10


Latest Institutional Activity in KRTX

Top Purchases

Q4 2023
Sofinnova Investments, Inc. Shares Held: 1.38M ($0)
Q4 2023
Wellington Management Group LLP Shares Held: 1.13M ($0)
Q4 2023
Pentwater Capital Management LP Shares Held: 1.07M ($0)
Q4 2023
Ubs Group Ag Shares Held: 422K ($0)
Q4 2023
Woodline Partners LP Shares Held: 357K ($0)

Top Sells

Q1 2024
Farallon Capital Management LLC Shares Held: 0 ($0)
Q1 2024
Ubs Oconnor LLC Shares Held: 0 ($0)
Q1 2024
Taconic Capital Advisors LP Shares Held: 0 ($0)
Q1 2024
Angelo Gordon & Co., L.P. Shares Held: 0 ($0)
Q1 2024
Treasurer Of The State Of North Carolina Shares Held: 0 ($0)

About KRTX

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.


Insider Transactions at KRTX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
202K Shares
From 4 Insiders
Exercise of conversion of derivative security 64K shares
Bona fide gift 90.9K shares
Other acquisition or disposition 47.4K shares
Sell / Disposition
1.83M Shares
From 21 Insiders
Sale (or disposition) back to the issuer 1.7M shares
Payment of exercise price or tax liability 15.7K shares
Open market or private sale 25K shares
Bona fide gift 90.9K shares

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX